From RationalWiki
Jump to: navigation, search
"That's the power of love!" - Huey Lewis & The News
Our secret stash of
Icon drugs.svg
Highs and lows

MDMA (3,4-methylenedioxy-N-methylamphetamine), commonly known as Ecstasy, is a drug primarily used to help white people dance :D [citation NOT needed]

The result however is usually a spastic, jerking movement with eyes rolled back into the head, listening to the Phish from Vermont, whilst jaw jutting out and the urge to touch everything all the while muttering about how much you love everyone.

MDMA is also an empathogenic psychedelic drug known to make talking to people easier, and tactile sensations more pleasant. It's generally regarded as safer than a lot of drugs; but is far from healthy for you physically. In contrast it was once used by psychotherapists for mental health and is being investigated for that purpose once more.


MDMA was first synthesized in 1912 by Merck chemist Anton Köllisch. At the time, Merck was interested in developing substances that stopped abnormal bleeding. In 1927, Max Oberlin studied the pharmacology of MDMA and observed that its effects on blood sugar and smooth muscles were similar to that of ephedrine. Researchers at Merck conducted experiments with MDMA in 1952 and 1959.[1] In 1953 and 1954, the United States Army commissioned a study of toxicity and behavioral effects in animals of injected mescaline and several analogues, including MDMA. The CIA experimented with MDMA as an interrogation tool in Project MKULTRA.[2] These originally classified investigations were declassified and published in 1973.[3]

MDMA was being used recreationally in the United States by 1970.[4] After MDMA was criminalized as a schedule 1 drug in 1985, most medical use stopped, although some therapists continued to prescribe the drug illegally.

Mechanisms of action[edit]

  1. MDMA increases oxytocin levels, which causes the feeling of ecstasy for which the drug is named.[5]
  2. MDMA increases activity in the ventromedial prefrontal cortex and decreases activity in the amygdala. These may cause a decrease in stress and fear, and an improvement in emotional regulation and decrease avoidance, respectively.[6]
  3. MDMA increases norepinephrine release and circulating cortisol levels, which may facilitate emotional engagement and enhance extinction of learned fear associations.[7]

Typically, users begin reporting subjective effects within 30 to 60 minutes of consumption, hitting a peak at about 75 to 120 minutes which plateaus coherently for about 3.5 hours. Users note peak serotonin occurs from 2.5–3 hours after ingestion. This is followed by a comedown of a few hours.

Apply directly to dancefloor[edit]

Ecstasy tablets

Recreational uses[edit]

In the rave environment, the sensory effects from the music and special effects like lasers are said to be enhanced by MDMA. MDMA lowers social inhibitions and provides energy for clubbing.[8] MDMA can increase self-confidence, extraversion, thoughtfulness and emotional sensitivity; in addition to getting you dazed and excited.[9] If you are lucky, you might get some hallucinations, but this is reportedly quite rare with pure MDMA.[10]

Although it is reported to make erections in men difficult, MDMA may result in an increased desire for emotionally intimate sex with whoever is available. Oxytocin is a hormone released following events such as hugging, orgasm, and childbirth, and is thought to facilitate bonding and the establishment of trust.[11]

Medical uses[edit]

MDMA has been indicated as possibly useful in psychotherapy, facilitating self-examination with reduced fear.[12] No research at all was allowed in the U.S. between 1985 and 1992, when the FDA approved Dr. Charles Grob to conduct human studies.[13] In the year 2000, Doctor José Carlos Bouso performed the first clinical trial of MDMA for use in treating Post Traumatic Stress Disorder in Spain, although this was stopped before the study was completed because of political pressure.[14] Some scientists believe MDMA may help those with disorders often associated with a lack of feeling connected to others, such as in schizophrenia, autism, or antisocial personality disorder.[15]


Real risks[edit]

  • MDMA causes dehydration which if left unattended can be dangerous or even fatal.[citation needed] Basically, you should have water with you, that you drink somewhat often, and you'll be fine.
  • Annoyingly, it also negatively impacts urination and sweating, so drinking too much water in compensation for dehydration can also cause dangerously low body salt levels.[citation needed]
  • It can temporarily worsen pre-existing heart and blood pressure problems.
  • It can cause low mood for a few days after use, which is mostly a placebo effect as a result of all the high oxytocin levels you've been feeling.
  • It can be difficult to cease habitual use. Low doses are preferable, and you can usually avoid addiction as long as you limit your consumption and make sure this isn't your only source of happiness.
  • Some MDMA is cut with harder drugs or poison, and a dealer won't always know what's in their product. Various raving goods stores sell testing kits. Or alternatively, you could just legalize and regulate the damn stuff.


This is Emmenthal, which is lovely. It is not your brain after taking MDMA.

As with most popular drugs, MDMA has given rise to a plethora of myths. Just an itsy-bitsy selection of those:

  • MDMA drains your spinal fluid. It really doesn't. That bad back on a terrible Tuesday morning is because you behaved like an idiot for four days.
  • There is a limited supply of MDMA and it will run out (quick take some more!).
  • MDMA turns your brain into Swiss cheese. Blame Oprah and her coterie of nut-job woo-meisters for this one.

Possible/debated risks[edit]

Many ravers perform badly on memory and intelligence tests. Is this because of MDMA, or because of alcohol and sleep deprivation? Probably alcohol and sleep deprivation.[16][17]

Street names[edit]

  • Ectasy
  • ADAM
  • Molly (US)
  • Mandy (UK)
  • MD (primarily UK)
  • E
  • X
  • XTC

See also[edit]


  1. Bernschneider-Reif S, Oxler F, Freudenmann RW (2006). "The origin of MDMA ('Ecstasy') – separating the facts from the myth". Pharmazie 61 (11): 966–972.
  2. Lowlinson JH, Ruiz P, Millman RB, Langrod JG. Substance Abuse: A Comprehensive Textbook. Williams & Wilkins. 1997. pp. 269–275.
  3. Hardman HF, Haavik CO, Seevers MH (1973). "Relationship of the Structure of Mescaline and Seven Analogs to Toxicity and Behavior in Five Species of Laboratory Animals". Toxicology Applied Pharmacology 25 (2): 299–309.
  4. Doblin, Rick. "A Clinical Plan for MDMA (Ecstasy) in the Treatment of Post-Traumatic Stress Disorder (PTSD): Partnering with the FDA". Multidisciplinary Association for Psychedelic Studies. Retrieved 9 December 2013.
  5. Dumont GJ1, Sweep FC, van der Steen R, et al (2009). "Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration". Soc. Neurosci. 2009;4(4):359-66.
  6. Gamma A, Buck A, Berthold T, et al (2000). "3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H215O]-PET in Healthy Humans". Neuropsychopharmacology (2000) 23, 388–395.
  7. Johansen PØ, Krebs TS (2009). "How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale". Journal of Psychopharmachology 23 (4):
  8. Reynolds, Simon (1999). Generation Ecstasy: Into the World of Techno and Rave Culture. Routledge. p. 81.
  9. Liechti ME, Gamma A, Vollenweider FX (2001). "Gender Differences in the Subjective Effects of MDMA". Psychopharmacology 154 (2): 161–168.
  10. Shulgin AT; Nichols DE (1978). "Characterization of Three New Psychotomimetics". In Willette, Robert E.; Stillman, Richard Joseph. The Psychopharmacology of Hallucinogens. New York: Pergamon Press. pp. 74–83
  11. Theodoridou A, Rowe AC, Penton-Voak IS, Rogers PJ (2009). "Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness". Horm Behav 56 (1): 128–32.
  12. Greer G. and Tolbert R. (1989). "The Therapeutic Use of MDMA", pp. 21–36 in Ecstasy: The Clinical, Pharmacological, and Neurotoxicological Effects of the Drug MDMA, Peroutka, SJ (ed.) Springer
  13. Julie Holland (2001). Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits. p. 20.
  14. Julie Holland (2001). Ecstasy: The Complete Guide: A Comprehensive Look at the Risks and Benefits. p. 391.